TCL Archive NCI Programs: NCI Drug Screening To Take More Targeted Approach; BSA Okays Plan To Support New MA Contracts April 3, 1998
TCL Archive In Brief: NIH AIDS William Paul To Step down; Aldige to Lead NCCR; Rimer Joins NCI October 10, 1997
TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
TCL Archive Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression November 30, 2012
